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Abstract We investigated the anti-obesity effect of the
aerial part of Artemisia scoparia Waldst. et Kit. (Composi-
tae). An 80 % aqueous EtOH extract of the aerial part
inhibited triglyceride (TG) accumulation and the nitric oxide
(NO) production activity. A new chromane derivative was
isolated from the aerial part of A. scoparia Waldst. et Kit.
along with 18 known compounds. The structure of the new
chromane, scopariachromane (1), was elucidated by spec-
troscopic analyses. The inhibitory effects of the compounds
on TG accumulation activity were examined. Among these,
cirsiliol (11) inhibited TG accumulation in 3T3-L1 preadi-
pocytes. Jaceosidin (12) inhibited NO production in a mur-
ine macrophage-like cell line (RAW 264.7). These results
indicate that the 80 % aqueous EtOH extract and com-
pounds isolated from the aerial part of A. scoparia Waldst. et
Kit. may improve obesity-related insulin resistance.
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Introduction
Obesity is one of the leading metabolic diseases worldwide
[1] and is closely associated with coronary heart disease,
hypertension, type 2 diabetes mellitus, cancer, respiratory
complications, and osteoarthritis [2]. Obesity is a condition
in which adipocytes accumulate a large amount of fat and
become enlarged. At the cellular level, this condition is
characterized by an increase in the number and size of
adipocytes that differentiate from 3T3-L1 preadipocytes in
the adipose tissue [3]. Recent studies have demonstrated
that the obese adipose tissue is characterized by enhanced
macrophage infiltration [4]. Macrophages produce various
inflammatory proteins such as tumor necrosis factor alpha
(TNF-a), monocyte chemoattractant protein-1 (MCP-1),
and nitric oxide (NO), which are implicated in insulin
resistance and metabolic disorders [5]. NO is a diffusible,
liposoluble, free radical gas produced from L-arginine by a
family of enzymes known as inducible NO synthases
(iNOS) [6]. In a co-culture system of RAW 264.7 macro-
phages and 3T3-L1 adipocytes, marked increases in the
secretion of inflammatory mediators such as TNF-a, MCP-
1, and NO were observed [7]. Triglyceride (TG) is syn-
thesized from glucose and fatty acid that is incorporated by
glucose transporter 4 and fatty acid transporter (CD36) into
3T3-L1 preadipocytes [8, 9]. Cultured 3T3-L1 adipocytes
have many properties similar to those of normal adipo-
cytes. Thus, this cell line is a suitable model system for
obesity-related research [10–12]. Herbal extracts from
plants such as Blumea balsamifera [13], Ginkgo biloba
[14], Wasabia japonica [15], Zizyphus jujuba [16], Morus
alba var. multicaulis [17], and Albizia julibrissin Durazz
[18] have been shown to possess anti-obesity effects. Thus,
we aimed to screen for crude drugs and natural products
with inhibitory effects on TG accumulation in adipocytes
and NO production in activated macrophages.
Artemisia scoparia Waldst. et Kit. belongs to the family
Compositae and is native to Japan, Korea, and Mongolia.
The aerial part of this plant is used in traditional medicine
as an antiphlogistic, as a diuretic, for the treatment of
hepatitis and urticaria, and as an antimold agent. Phyto-
chemical investigations of the aerial part of A. scoparia
Waldst. et Kit. resulted in the isolation of flavonoids,
coumarins, and essential oils [19].
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In the present study, we found that an 80 % aqueous
EtOH extract of A. scoparia Waldst. et Kit. inhibited TG
accumulation [22.5 % (30 lg/mL)] in 3T3-L1 adipocytes
and NO production [24.3 % (30 lg/mL)] by RAW 264.7,
which were activated by lipopolysaccharide (LPS) and
recombinant mouse interferon gamma (IFN-c).
Therefore, we analyzed A. scoparia Waldst. et Kit. to
identify the active compounds in the extract. Through
bioactivity-guided fractionation, we identified a new
chromane derivative, scopariachromane (1), and 18 known
compounds from the aerial part of A. scoparia Waldst. et
Kit. Herein, we describe the structural elucidation and
biological evaluation of these compounds.
Results and discussion
The aerial parts of A. scoparia Waldst. et Kit. were
extracted with 80 % aqueous EtOH. The 80 % aqueous
EtOH extract was suspended in H2O and partitioned with
n-hexane, CHCl3, EtOAc, and n-BuOH, successively. The
CHCl3 and EtOAc layers showed inhibitory effects on TG
accumulation [41.9 and 10.4 %, respectively (30 lg/mL)]
and NO production [55.4 and 33.1 %, respectively (10 lg/
mL)]. Bioassay-directed fractionation led to the isolation of
a new chromane derivative, named scopariachromane,
together with 18 known compounds (2–19) (Fig. 1).
Scopariachromane (1) was isolated as an amorphous
colorless powder, and its molecular formula was deter-
mined as C15H18O5 by HR-EI-MS, with seven degrees of
unsaturation. The UV spectrum of 1 showed absorption at
295 and 232 nm, and its IR spectrum showed the charac-
teristic absorption bands of hydroxyl groups (3420 cm-1), a
conjugated carbonyl group (1694 cm-1), and conjugated
double bonds (1633 and 1609 cm-1). The 1H NMR chem-
ical shifts of 1 (Table 1) indicated the presence of a 1,2,4-
trisubstituted aromatic ring at dH 7.74 (1H, d, J = 1.8 Hz,
H-5), dH 7.47 (1H, dd, J = 8.7, 1.8 Hz, H-7), and dH 6.76
(1H, d, J = 8.7 Hz, H-8); a trans-olefin at dH 7.60 (1H, d,
J = 15.9 Hz, H-10) and dH 6.36 (1H, d, J = 15.9 Hz, H-20);
a methoxy proton at dH 3.72 (3H, s, OCH3-30); and two
methyl at dH 1.45 (3H, s, H-2a) and dH 1.22 (3H, s, H-2b).
Analysis of the 13C NMR (Table 1) and DEPT spectra
revealed the presence of one carbonyl group, one methoxy
group, two methyls, seven methines, and five quaternary
carbons. All protonated carbons were assigned by HMQC
analysis. Furthermore, the 1H–1H COSY (Fig. 2) spectrum
indicated connectivity between methine protons at dH 4.55
(H-4) and dH 3.56 (H-3), H-10 and H-20, respectively.
HMBC analysis of 1 (Fig. 2) showed long-range correla-
tions between H-4 and dC 79.8 (C-2) and dC 75.9 (C-3); H-3
and C-2, dC 27.1 (C-2a) and dC 19.7 (C-2b); H-2b and C-2,
and C-3; and H-2a and C-2, and C-3, which indicated the
presence of a prenyl-type unit. Furthermore, H-5 and dC
Fig. 1 Structures of
compounds isolated from
Artemisia scoparia Waldst. et
Kit
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126.1 (C-10) and dC 69.1 (C-4); H-4 and dC 129.2 (C-5) and
C-10; and H-3 and C-10 indicated that the prenyl-type unit
was located on C-4. The degree of unsaturation at seven
also indicated that the prenyl-type unit participated in a
cyclic structure. The NOESY spectrum of 1 (Fig. 3) showed
correlations between H-2a and H-3, and H-2b and H-4.
These results suggested a quasi-trans axial. The coupling
constant between H-3 and H-4 (J = 8.7 Hz) indicated that
these protons were trans diaxial. This analysis and a com-
parison with published data indicated that 1 was a
(3R*,4S*)-3,4-dihydroxy-2,2-dimethyl-chroman derivative
[20]. In addition, HMBC correlations between H-5 and
C-10; H-20 and dC 167.2 (C-30); H-20 and dC 127.1 (C-6); and
dH 3.72 (OCH3-30) and C-30 were observed. Thus, the rel-
ative structure of 1 was determined to be scopariachromane.
The known isolated compounds were readily identified
by comparison of physical and spectral data with published
values. These compounds included three p-coumaric acid
derivatives, drupanin (2) [21], methyl 3-[40-hydroxypre-
nyl]coumarate (3) [22], and methyl 1-(30,40-dihydroxy-
phenyl)propenoate (4) [23]; five flavanes, sakuranetin (5)
[24], naringenin (6) [25], blumeatin (7) [26], 30,5,50,7-tet-
rahydroxyflavanone (8) [26], and eriodictyol (9) [27]; four
flavones, cirsilineol (10) [28], cirsiliol (11) [28], jaceosidin
(12) [29], and 5,7,20,40-tetrahydroxy-6,50-dimethoxyflavone
(13) [30]; two flavonols, axillarin (14) [31] and hyperin
(15) [32]; a flavanonol, 7-methoxytaxifolin (16) [33]; a
coumarin, scopoletin (17) [34]; a benzoic acid derivative,
vanillic acid (18) [35]; and a chromone derivative, 6-de-
methoxycapillarisin (19) [36]. Compounds 2, 3, 5–9, 13,
14–16, and 18 were isolated for the first time from the
aerial part of A. scoparia Waldst. et Kit.
The isolated compounds were evaluated for their inhibi-
tory effects against intracellular TG accumulation in 3T3-L1
cells. To determine their nontoxic concentrations, 3T3-L1
cells were treated with various concentrations (3–100 lM)
of 1–19, and the cell viability was measured by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. None of the compounds were cytotoxic at
concentrations up to 30 lM. Thus, we used a concentration
of at most 30 lM. TG measurements were corrected for the
amount of DNA. Quercetin, which has been reported to have
inhibitory effects on TG accumulation, was used as a posi-
tive control [37]. Treatment with 7, 10, 11, and 16 (30 lM)
inhibited TG accumulation (Table 2). In particular, 11
potently inhibited intracellular TG accumulation. Compared
with 10, 11 showed a stronger inhibitory effect on TG
accumulation. These results suggest that the presence of a
hydroxy group at C-30 could be important. We also examined
the effects of 7, 10, 11, and 16 on the uptake of [1-3H]-2-
deoxy-D-glucose (Table 3). TG is synthesized from glucose
and fatty acid that are incorporated by glucose transporter 4
and fatty acid transporter CD36 [8, 38]. These compounds
inhibited glucose uptake for TG synthesis in 3T3-L1 adi-
pocytes. In addition, we have examined the inhibitory effects
of 1–19 on NO production in RAW 264.7 cells. As shown in
Table 4, compounds 1–14, 16, 17, and 19 showed inhibitory
activity. These compounds did not have cytotoxic effects
(10–30 lM). In the assay, aminoguanidine (IC50 17.5 lM),
which has been reported to have inhibitory effects on NO
production in LPS-activated RAW 264.7 macrophages via
the downregulation of iNOS, was used as a positive control
[39]. Compounds 4, 5, 7–11, 12–14, 16, and 17 showed
strong or moderate inhibitory effects on NO production
compared with aminoguanidine (Table 4). Of the 19
Fig. 2 Key COSY and HMBC correlations for 1
Fig. 3 Key NOE correlations for 1
Table 1 1H (300 MHz) and13C NMR (75 MHz) data for compound




2a 27.1 1.45 (3H, s)
2b 19.7 1.22 (3H, s)
3 75.9 3.56 (1H, d, J = 8.7)
4 69.1 4.55 (1H, d, J = 8.7)
5 129.2 7.74 (1H, d, J = 1.8)
6 127.1
7 129.0 7.47 (1H, d, J = 8.7, 1.8)
8 117.7 6.76 (1H, d, J = 8.7)
9 154.9
10 126.1
10 144.8 7.60 (1H, d, J = 15.9)
20 115.4 6.36 (1H, d, J = 15.9)
30 167.2
OCH3 54.4 3.72 (3H, s)
Chemical shifts are given in ppm; coupling constants J (in paren-
theses) are given in Hz
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compounds tested, compound 12 exhibited the highest
inhibitory activity against NO production (IC50 5.9 lM).
In brief, the results presented here showed that an 80 %
aqueous EtOH extract of the aerial part of A. scoparia
Waldst. et Kit. and the isolated compounds may be used to
reduce obesity, which is a serious health problem in
industrialized countries, by inhibiting NO production by
activated macrophages, and intracellular TG accumulation
and glucose uptake in mature adipocytes.
Experimental
General experimental procedure
Optical rotation (OR) was measured in MeOH using a
JASCO P-1020 polarimeter. The UV spectra were obtained
in MeOH using a JASCO V-550 spectrophotometer, and
the IR spectra were recorded using a JASCO IR A-2
spectrophotometer. The NMR spectra were recorded using
a JEOL ECX-500 spectrometer (1H NMR, 500 MHz; 13C
NMR, 125 MHz), with TMS as an internal standard. Mass
spectra were obtained using a JEOL GCmate spectrometer.
Silica gel 60 N (Kanto Chemical Corp.), YMC GEL ODS-
A (YMC Co. Ltd.), and Sephadex LH-20 (GE Healthcare)
were used for column chromatography (CC). TLC was
performed using TLC plates (thickness 0.25 mm, F254;
Merck), and compounds were visualized by spraying with
5 % (v/v) H2SO4 in EtOH and vanillin reagent. HPLC was
performed using a JASCO PU-1580 apparatus equipped
with a JASCO UV-1575 detector and a Shodex OR-2 OR
detector. Cosmosil 5C18-MS-II (10 9 250 mm i. d. and
4.6 9 250 mm i. d.; Nacalai Tesque), Cosmosil Cholester
(10 9 250 mm i. d.; Nacalai Tesque), and Cosmosil p nap
(10 9 250 mm i. d.; Nacalai tesque) were used for pre-
parative purposes.
Plant materials
The aerial part of A. scoparia Waldst. et Kit. was collected
from Inner Mongolia during 2003. An authentic specimen
of this plant was deposited in the Laboratory of Pharma-
cognosy, School of Pharmacy, Nihon University, Japan
(NK-03040).
Extraction and isolation
The aerial part of Artemisia scoparia Waldst. et Kit. (5 kg)
was extracted 3 times with 80 % aqueous EtOH. Evapo-
ration of the solvent under reduced pressure from the
combined extract afforded the EtOH extract (265 g). The
extract was suspended in H2O (1:1, v/v) and partitioned
with n-hexane (4 9 1:1, v/v), CHCl3 (4 9 1:1, v/v),
EtOAc (4 9 1:1, v/v), and n-BuOH (4 9 1:1, v/v),
Table 2 Effects of compounds 1–19 on TG accumulation in cultured
3T3-L1 adipocytes
Inhibition (%) Inhibition (%)
1 5.9 ± 3.0 11 77.0 ± 0.9**
2 7.1 ± 3.2 12 20.1 ± 14.3
3 -1.5 ± 5.0 13 4.0 ± 3.0
4 5.7 ± 7.1 14 19.1 ± 0.9
5 13.2 ± 3.6 15 -10.6 ± 4.2
6 2.6 ± 11.0 16 49.8 ± 9.6*
7 38.9 ± 3.1* 17 18.5 ± 1.3
8 -2.4 ± 4.0 18 -37.8 ± 6.1
9 -10.5 ± 3.0 19 -8.8 ± 3.6
10 37.2 ± 3.7* Quercetin 38.4 ± 3.4
Cells were treated with compounds 1–19 (30 lM) on days 0 and 3.
On day 8, the intracellular TG content of the cells was measured
Results are expressed as mean ± SE of 3 individual experiments
*p \ 0.05, **p \ 0.01 vs. control (Student’s t test)
Table 3 Effect of compounds 7, 10, 11, and 16 on glucose uptake in
3T3-L1 cells
Inhibition (%) Inhibition (%)
7 44.4 ± 3.2* 16 19.8 ± 3.2
10 67.4 ± 1.3** Quercetin 20.3 ± 1.7
11 63.1 ± 0.2**
After cell differentiation, the medium was replaced with serum-free
DMEM for 2 h, and the cells were washed and incubated in KRH
buffer containing insulin (200 nM) for 10 min. After exposure to
insulin, they were treated with samples in KRH buffer for 15 min.
After incubation, [1-3H]-2-deoxy-D-glucose (0.25 lCi/mL) was
added, and incubation was continued for 10 min. The cells were
solubilized in 0.1 % SDS. The incorporated radioactivity was mea-
sured by liquid scintillation counting
Results are expressed as the mean ± SE of 3 individual experiments
*p \ 0.05, **p \ 0.01 vs. control (Student’s t test)
Table 4 Inhibitory effects of the isolated compounds 1–19 on NO
production stimulated by LPS and IFN-c in RAW 264.7 cells
IC50 (lM) IC50 (lM)
1 73.7 11 18.0
2 46.4 12 5.9
3 41.2 13 13.0
4 21.1 14 23.1
5 25.1 15 [100
6 55.2 16 13.7
7 20.6 17 21.1
8 25.7 18 [100
9 27.3 19 38.2
10 13.1 Aminoguanidine 17.5
J Nat Med (2014) 68:414–420 417
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successively. The amounts extracted were 0.543, 4.43,
30.0, and 56.6 g, respectively, and the residual aqueous
extract yielded 135.1 g of material. The CHCl3 extract was
subjected to silica gel CC, [n-hexane/EtOAc (100:0 ?
0:100, v/v)] to yield Fr. C-1–C-16. Fr. C-5 (409 mg) was
purified by reversed-phase HPLC with H2O/MeOH (70:30,
v/v) to yield 5 (93.6 mg). 7 (44 mg) was crystallized from
Fr. C-7 (559 mg) using MeOH. Fr. C-8 (213 mg) was
purified by reversed-phase HPLC with H2O/MeOH (43:57,
v/v) to yield 2 (2.5 mg).
Fr. C-9 (624 mg) was subjected to ODS CC [H2O/MeOH
(90:10 ? 0:100, v/v)] to yield Fr. C-9-1–C-9-5. Fr. C-9-2
(416 mg) was purified by reversed-phase HPLC with H2O/
MeOH (65:35, v/v) to yield 3 (96 mg), and 12 (9.0 mg). Fr.
C-10 was purified by reversed-phase HPLC with H2O/
MeOH (35:65, v/v) to yield 1 (7.6 mg), 10 (4.0 mg), and 17
(8.6 mg). The EtOAc extract was subjected to silica gel CC
[CHCl3/MeOH (100:0 ? 0:100, v/v)] to yield Fr. E-1–E-5.
Fr. E-2 (2463 mg) was subjected to ODS CC [H2O/MeOH
(90:10 ? 0:100, v/v)] to yield Fr. E-2-1–E-2-6. Fr. E-2-1
(329.1 mg) was subjected to Sephadex LH-20 CC [H2O–
MeOH (50:50, v/v)] to yield Fr. E-2-1-1–E-2-1-3. Fr. 2-1-2
(28.9 mg) was purified by reversed-phase HPLC with H2O/
MeOH (50:50, v/v) to yield 18 (7.7 mg). Fr. E-2-3 (845 mg)
was purified by reversed-phase HPLC with H2O/CH3CN
(60:40, v/v) to yield 4 (96 mg), 6 (29.3 mg), 8 (15.8 mg), 11
(40.7 mg), 13 (12.3 mg), 16 (39.7 mg), and 19 (12.9 mg).
Fr. E-3 (2781 mg) was subjected to ODS CC [H2O/MeOH
(90:10 ? 0:100, v/v)] to yield Fr. E-3-1–E-3-5. Fr. E-3-3
(518 mg) was purified by reversed-phase HPLC with H2O/
CH3CN (60:40, v/v) to yield 9 (98.1 mg). Fr. E-3-4
(701 mg) was subjected to Sephadex LH-20 CC [H2O/
MeOH (20:80, v/v)] to yield Fr. E-3-4-1–E-3-4-12. Fr. E-3-
4-7 (26.8 mg) was purified by reversed-phase HPLC with
H2O/CH3CN (60:40, v/v) to yield 14 (3.8 mg). Fr. E-5
(9206.2 mg) was subjected to ODS CC [H2O/MeOH
(90:10 ? 0:100, v/v)] to yield Fr. E-5-1–E-5-7. Fr. E-5-4
(1557 mg) was purified by reversed-phase HPLC with H2O/
CH3CN (10:90, v/v) to yield Fr. E-5-4-1–E-5-4-3. 15
(47.7 mg) was crystallized from Fr. E-5-4-2 (370.9 mg)
using MeOH.
Scopariachromane (1): amorphous colorless powder.
½a25D –40.3 (c = 1.0, MeOH). UV kmax (MeOH) nm (log e):
215 (4.00), 232 (3.99), 295 (4.03). IR (KBr) mmax cm
-1:
3420 (OH), 1694 (conj. C=O), 1633 (conj. C=C). EI-MS
m/z: 232 [M]?. HR-EI-MS m/z: 278.1153 (calcd for
C15H18O5, 278.1154). The
1H and 13C NMR spectral data
for 1 are presented in Table 1.
Nitrite assay
The cells were seeded at 1.2 9 106 cells/mL onto 96-well
flat-bottom plates (Sumitomo Bakelite) and incubated at
37 C for 2 h. The test sample was then added to the cul-
ture simultaneously with Escherichia coli LPS (100 ng/
mL) and recombinant mouse IFN-c (0.33 ng/mL), and the
cells were incubated at 37 C, usually for 16 h. After
incubation, the cells were chilled on ice. The culture
supernatant (100 lL) was placed in wells in duplicate
96-well flat-bottom plates. A standard solution of NaNO2
was also placed in other wells on the same plates. To
quantify nitrite, 50 lL Griess reagent, 1 % sulfanilamide in
5 % H3PO4, and 0.1 % N-(1-naphthyl)ethylenediamide
dihydrochloride were added to each well. After 10 min, the
reaction products were colorimetrically quantified at
550 nm with subtraction of the background absorbance at
630 nm, using a model 3550 microplate reader (BIO-
RAD).
TG assay
3T3-L1 preadipocytes (American Type Culture Collection)
were plated in 24-well plates and maintained in DMEM
supplemented with 10 % (v/v) fetal calf serum (FCS) and
1 % (v/v) penicillin–streptomycin at 37 C in a humidified
5 % CO2 incubator. To induce differentiation, 3-day
postconfluent 3T3-L1 preadipocytes (day 0) were stimu-
lated by adipogenic agents (500 lM 3-isobutyl-1-methyl-
xanthine, 1 lM dexamethasone, and 10 lg/mL insulin)
that were added to DMEM with 10 % (v/v) fetal bovine
serum (FBS) culture medium. After 3 days, the medium
was replaced with DMEM containing 10 % (v/v) FBS and
5 lg/mL insulin, and it was subsequently replaced every
3 days. The cells were harvested 8 days after the initiation
of differentiation. The cells were washed with PBS (-),
scraped on ice in 500 lL of sonication buffer (25 mM Tris
buffer and 1 mM EDTA; pH 7.5), and sonicated to
homogenize the cell suspension. The total TG content of
the cells was determined using the LabAssayTM triglycer-
ide kit (Wako Pure Chemical Industries, Ltd., Osaka,
Japan). The DNA concentration was determined using the
DNA quantity kit (Primary Cell Co., Ltd., Sapporo, Japan).
The TG concentration per microgram of DNA in 3T3-L1
cells was expressed as the ratio (%) relative to the control
value. The test sample dissolved in DMSO was added.
Glucose uptake assay
3T3-L1 adipocytes were harvested 8 days after the initia-
tion of differentiation. After the differentiation, the med-
ium was replaced with serum-free DMEM for 2 h, and the
cells were then washed and incubated in KRH buffer
(25 mM HEPES, 120 mM NaCl, 5 mM KCl, 1.2 mM
KH2PO4, 1 mM CaCl2, 1 mM MgSO4; pH 7.4) containing
insulin (200 nM) for 10 min at 37 C. After exposure to
insulin, the cells were washed and treated with samples in
418 J Nat Med (2014) 68:414–420
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KRH buffer for 15 min. After incubation, [1-3H]-2-deoxy-
D-glucose (0.25 lCi/mL) was added, and incubation was
continued for 10 min. The cells were washed twice with
ice-cold KRH buffer and then solubilized with 0.1 % SDS.
The incorporated radioactivity was measured by liquid
scintillation counting. Nonspecific uptake was determined
in the presence of 20 lM cytochalasin B and was sub-
tracted from the total value. The test sample dissolved in
DMSO was added.
Cell viability assay
Cell viability was assessed using MTT. The 3T3-L1 cells
(1.0 9 105 cells/mL) were seeded in 96-well plates and
incubated for 24 h at 5 % CO2 and 37 C and then treated
with samples. After 24 h of incubation, 20 lL of MTT
solution (1 mg/mL) was added to the cell culture, and the
cells were further incubated at 37 C and 5 % CO2 for 4 h.
After removing the medium, the MTT formazan crystals
were dissolved in DMSO, following which the absorbance
in individual wells was determined at 570 nm using a
microplate reader and the background absorbance
(655 nm) was subtracted. The test sample dissolved in
DMSO was added.
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